Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4674531 | 0.90 | HTR6 (0.64) | HTR6SCN9A | |
| SCHEMBL4676869 | 0.90 | HTR6 (0.64) | HTR6SCN9A | |
| SCHEMBL3343253 | 0.90 | HTR6 (0.55) | HTR6SCN9A | |
| SCHEMBL3343726 | 0.90 | HTR6 (0.59) | HTR6SCN9A | |
| SCHEMBL4676433 | 0.89 | HTR6 (0.63) | HTR6SCN9A | |
| Hydrochloric Acid SCHEMBL4674835 | 0.89 | HTR6 (0.63) | HTR6SCN9A | |
| Hydrochloric Acid SCHEMBL4672725 | 0.89 | HTR6 (0.74) | HTR6 | |
| SCHEMBL4676589 | 0.89 | HTR6 (0.74) | HTR6 | |
| SCHEMBL3339149 | 0.89 | HTR6 (0.70) | HTR6 | |
| Hydrochloric Acid SCHEMBL4673582 | 0.89 | HTR6 (0.62) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080039462-A1 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION | 2008-02-14 | — | — | US | claimed |
| EP-1964544-B2 | Sensitive skin perfumes | TAKASAGO PERFUMERY CO LTD (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-1964544-B1 | Sensitive skin perfumes | TAKASAGO PERFUMERY CO LTD (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20100152306-A1 | Sensitive Skin Perfumes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100152177-A1 | COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-06-17 | — | — | US | disclosed |
| US-20100152177-A1 | COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-06-17 | — | — | US | disclosed |
| US-20100152177-A1 | COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-06-17 | — | — | US | disclosed |
| US-7696229-B2 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-04-13 | — | — | US | disclosed |
| US-7696229-B2 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-04-13 | — | — | US | disclosed |
| US-7696229-B2 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-04-13 | — | — | US | disclosed |
| US-20080241201-A1 | Cosmetics, toiletries, personal care and cleansing, household cleaning and laundry products having two to ten well characterized fragrances; hypoallergenic | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| EP-1964544-A1 | Sensitive skin perfumes | Takasago International Corporation (JP) | 2008-09-03 | — | — | EP | disclosed |
| EP-1964542-A1 | Sensitive skin perfumes | Takasago International Corporation (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-20080039462-A1 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION | 2008-02-14 | — | — | US | disclosed |
| US-20080039462-A1 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION | 2008-02-14 | — | — | US | disclosed |
| US-20080039462-A1 | Compounds having 5-HT6 receptor affinity | MEMORY PHARMACEUTICALS CORPORATION | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152177-A1 | COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | HTR6, HTR3B, HTR1B | HTR6 1/4885SCN9A 1368/4885 |
| US-20080039462-A1 | Compounds having 5-HT6 receptor affinity | HTR6, HTR3B, HTR1B | HTR6 1/4885SCN9A 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.